Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Anne Valente MD

Anne Marie Valente MD

Co-Director, Pregnancy and Cardiovascular Disease Program at Brigham and Women's Hospital; Director, Boston Adult Congenital Heart Disease Program, Boston Children's Hospital and the Brigham and Women's Hospital; Professor of Pediatrics, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Dr. Valente is a Professor of Pediatrics and an Associate Professor of Medicine at Harvard Medical School. She received a BS from Boston College and MD from the University of Vermont College of Medicine. She completed residency in Internal Medicine and Pediatrics and fellowship in Pediatric Cardiology and Adult Cardiovascular Disease at Duke University.

She is the Director of the Boston Adult Congenital Heart (BACH) Disease and Pulmonary Hypertension Program at Boston Children's Hospital and Co-Director of the Pregnancy and Cardiovascular Disease Program at the Brigham and Women’s Hospital.

Her expertise is in cardiovascular imaging with a focus in cardiac magnetic resonance imaging. Dr. Valente's research interests include strategies to improve the outcomes of women with heart disease during pregnancy and investigations into the mechanisms that contribute to ventricular dysfunction in adults with congenital heart disease. She is the primary investigator for the INDICATOR trial, which is an international multicenter registry to determine predictors of adverse clinical outcomes in patients with repaired tetralogy of Fallot.


Dr. Valente reports the following:

  • American College of Cardiology (Editorial board member, JACC)